Boston Scientific (BSX) is a publicly traded Healthcare sector company. As of November 15, 2026, BSX trades at $44.34 with a market cap of $64.27B and a P/E ratio of 17.14. BSX moved -0.20% today. Year to date, BSX is -53.56%; over the trailing twelve months it is -57.76%. Its 52-week range spans $39.57 to $109.50. Analyst consensus is buy with an average price target of $50.05. Rallies surfaces BSX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BSX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $44.34 |
| Market Cap | $64.27B |
| P/E Ratio | 17.14 |
| EPS | $2.49 |
| Dividend Yield | 0.00% |
| 52-Week High | $109.50 |
| 52-Week Low | $39.57 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $21.00B |
| Net Income | $3.67B |
| Gross Margin | 69.93% |
22 analysts cover BSX: 0 strong buy, 14 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $50.05.